Skip to content
Juul Ban will send Altria’s strategy and $13 billion up in smoke

Altria Group disastrous investment in Juul Labs takes another turn for the worse.

On Wednesday, the Wall Street Journal reported that the Food and Drug Administration was preparing to pull Juul e-cigarettes from the US market. Banning Juul in the United States, where it was on track to make 94% of its revenue this year, would put the company in grave danger.